Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and ketamine prophylaxis for postoperative pain and emergence delirium after pediatric tonsillectomy
IRCT20210712051848N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain and Emergence agitation (EA) comparing Dexmedetomidine, Ketamine and Placebo (3 arms). Primary endpoints: Postoperative pain and Emergence delirium. Started Jan 2019; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
postoperative painEmergence agitation (EA)
Beyond the preview
Go deeper on IRCT20210712051848N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210712051848N2.